Evoltra and renal failure acute Patient Reports February 13, 2012

Evoltra Side Effects Report #6139727-2
Evoltra side effect was reported by a Health Professional from UNITED KINGDOM on Mar 16, 2009. Female patient, 77 years of age, was diagnosed with myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cardiac arrest , clostridium difficile toxin test positive, left ventricular failure, myocardial ischaemia, neutropenic sepsis, renal failure acute. Evoltra dosage: 42 MG, QDX5, INTRAVENOUS. During the same period patient was treated with DAUNORUBICIN, LEVOTHYROXINE, ALLOPURINOL, ACETAMINOPHEN, ONDANSETRON. Patient was hospitalized. Patient died on 01/25/2009.

Evoltra Side Effects Report #6074383-3
Evoltra side effect was reported by a Physician from UNITED STATES on Jan 29, 2009. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cardiac arrest , neutropenic sepsis, renal failure acute. Evoltra dosage: unknown. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 01/25/2009.

Evoltra Side Effects Report #6106875-2
Evoltra side effect was reported by a Physician from UNITED KINGDOM on Feb 20, 2009. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, myocardial ischaemia, neutropenic sepsis, renal failure acute. Evoltra dosage: unknown. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 01/25/2009.

Evoltra Side Effects Report #5945573-2
Evoltra side effect was reported by a Physician from FRANCE on Oct 28, 2008. Female patient, child 8 years of age, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: aplasia, haemodialysis, renal failure acute. Evoltra dosage: unknown. Patient recovered.


Evoltra Side Effects Report #5963753-7
Evoltra side effect was reported by a Physician from FRANCE on Nov 12, 2008. Female patient, child 8 years of age, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: aplasia, haemodialysis, multi-organ failure, renal failure acute. Evoltra dosage: unknown. During the same period patient was treated with ENDOXAN, ETOPOSIDE. Patient died on 11/09/2008.

Evoltra Side Effects Report #5985284-0
Evoltra side effect was reported by a Consumer or non-health professional from FRANCE on Nov 24, 2008. Female patient, child 6 years of age, weighting 35.27 lb, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: capillary leak syndrome, febrile bone marrow aplasia, haemodialysis, multi-organ failure, renal failure acute, respiratory failure. Evoltra dosage: unknown. During the same period patient was treated with ENDOXAN, ETOPOSIDE, TAZOCILLINE, AMIKACIN, FASTURTEC, NUBAIN, ZOVIRAX, ZOFRAN. Patient died on 11/09/2008.

Evoltra Side Effects Report #6125932-8
Evoltra side effect was reported by a Physician from UNITED KINGDOM on Mar 05, 2009. Male patient, 15 years of age, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: cardiac failure acute, dialysis , renal failure acute. Evoltra dosage: 72 MG QDX5; INTRAVENOUS. Patient died on 03/05/2009.